ESCMID guidelines for the management of the infection control measures to reduce transmission of multidrug-resistant Gram-negative bacteria in hospitalized patients. Cl Microb Infect, 2014
Prevention and control of multi-drug-resistant Gram-negative bacteria: recommendations from a Joint Working Party. Journal of Hospital Infection, 2016
OMS (traduzione Ministero dela Salute) Linee guida per la prevenzione e il controllo di Enterobatteri, Acinetobacter baumannii e Pseudomonas aeruginosa resistenti ai carbapenemi nelle strutture sanitarie. 2017 (traduzione 2020)
Infection prevention and control measures and tools for the prevention of entry of carbapenem-resistant Enterobacteriaceae into healthcare settings: guidance from the European Centre for Disease Prevention and Control (2017)
Guidelines for the prevention and control of carbapenem-resistant Enterobacteriaceae, Acinetobacter baumannii and Pseudomonas aeruginosa in health care facilities. WHO, 2017
Implementation manual to prevent and control the spread of carbapenem-resistant organisms at the national and health care facility level. WHO, 2019
Guidelines for the Prevention and Control of Multi-drug resistant organisms (MDRO) excluding MRSA in the healthcare setting. Ireland, 2012
Framework of actions to contain carbapenemase-producing Enterobacterales. UK Health Security Agency, Septembre 2022
SHEA/HICPAC Position Paper. Recommendations For Metrics For Multidrug-Resistant Organisms In Healthcare Settings. 2008
